Oppenheimer Upgrades Outlook on Marvell Technology With Price Target Boost GitHubs AI Coding Ambitions Face Outage Setbacks as Competition Intensifies Trumps Latest AIGenerated Posts Rekindle Greenland Interest Raising Geopolitical and Market Implications Oil Prices Hold Decline as USIran Talks Progress Toward Strait of Hormuz Reopening Harikanta Overseas IPO Day 4 Subscription Crosses 50 Milestone Check GMP and Key Offer Details Beyond to Acquire Buy Buy Baby Brand Rights Reuniting It with Bed Bath Beyond CRS Q1 2026 Earnings Earnings Beat on Solid Demand Stock Slips Despite Beat PRU Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment Despite Modest Stock Dip VLYPP Q1 2026 Earnings Preferred Dividend Coverage Solid as EPS Beats Estimates BIP Q1 2026 Earnings Significant EPS Miss Sends Shares Lower Meritage Homes MTH Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Sentiment GRAL Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher Fractyl Health GUTS Slides 296 as Stock Tests Key Support Levels NuCana NCNA Nears Support as Shares Edge Lower on Light Trading Ocean Power Technologies OPTT Surges 7 as Renewables Momentum Builds Saratoga Investment Corp Note SAY Holds Steady Near Support as Bond Market Awaits Rate Cues Shuttle Pharmaceuticals SHPH Declines 493 as Investors Eye Key Support at 055 Lenovo Shares Surge Over 15 on Record Earnings as AI Revenue Nearly Doubles Cineverse Q1 2026 Earnings SmallerThanExpected Loss as EPS Beats Estimates Installed Building Products Faces Headwinds Holds Above Key Support Levels AgEagle Aerial Systems UAVS Posts Modest Gain at 106 Resistance at 111 in Focus Kayne Anderson Energy Infrastructure Fund KYN Faces Slight Pullback as Energy Sector Volatility Persists Dune Acquisition Corp II Warrants IPODW Hold Steady at 030 Amid Low Volume Consolidation Blueport Acquisition Ltd BPAC Holds Steady Near 1009 Amid SPAC Market Consolidation Patriot National Bancorp PNBK Drops 637 as Shares Press Key 090 Support DirectBooking Technology ZDAI Bounces from Support Levels Eyes Resistance at 214 Bicara Therapeutics BCAX Edges Higher as Stock Tests Key Resistance Zone